Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CC-5013-DLC-001
Abstract
Realization of a part of clinical trial called Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)